课题基金 / 基金详情

STTR Phase I: Rapid Diagnosis of Tuberculosis at the Point of Care Using a Handheld Volatile Biomarker Sensor

STTR Phase I: Rapid Diagnosis of Tuberculosis at the Point of Care Using a Handheld Volatile Biomarker Sensor
STTR 第一阶段:使用手持式挥发性生物标志物传感器在护理点快速诊断结核病
批准号:
1321530
负责人:
Swomitra Mohanty
金额:
$22.23万
依托单位国家:
美国
项目类别:
Standard Grant
财政年份:
2013
资助国家:
美国
项目状态:
已结题
起止时间:
2013-07-01 至 2014-12-31

项目摘要

项目成果

Swomitra Mohanty的其他基金

相似基金

相关文献

中文摘要
翻译
小企业技术转让(STTR)第一阶段项目旨在开发一种廉价快速的传感技术,用于在护理点(POC)检测结核病(TB)。在农村地区快速筛查结核病是困难的,因为目前的诊断方法昂贵,耗时(几天到几周),并需要专门的设备(实验室和医院),而这些设备在农村结核病流行地区并不容易获得。 这种传感技术利用基于金属功能化3D TiO 2纳米管阵列的固态传感器,该纳米管阵列结合由导致TB的分枝杆菌释放的特定挥发性生物标志物。 最终用户的读数是一个电子信号,根据电流的变化给出快速的正/负答案。 该传感器操作简单,不需要用于感测的专用生物试剂(即抗体、荧光标签等),并且需要简单的恒电位仪进行操作。 该项目有可能开发成一种廉价的快速POC设备,用于使用类似呼吸测醉器的设备对结核病风险人群进行筛查,该设备需要最少的操作培训。 结核病是世界上一种毁灭性的传染病,全世界约有1400万人感染。虽然西方世界的发病率有所下降,但在亚洲和非洲国家内仍有世界范围的大流行。 该公司打算满足市场对结核病快速诊断的需求,特别是在农村地区诊断结核病资源不足的流行国家。 此外,预计该项目将把TiO 2纳米管传感平台的应用扩展到结核病和其他领域以外的其他疾病。 例如,已知VOB与心脏移植排斥、肺癌、缺血性心脏病、妊娠先兆子痫、糖尿病和乳腺癌相关。 该技术也可应用于非生物医学应用,如检测饮用水中的挥发性有机化合物和检测简易爆炸装置。
英文摘要
This Small Business Technology Transfer (STTR) Phase I project is to develop an inexpensive and rapid sensing technology for detection of tuberculosis (TB) at the point of care (POC). Rapid screening of TB in rural areas is difficult because current diagnostic methods are expensive, time consuming (several days to weeks), and require specialized equipment (laboratories and hospitals) that are not readily available in rural TB rampant areas. This sensing technology utilizes a solid-state sensor based on metal functionalized 3D TiO2 nanotube arrays that bind specific volatile biomarkers that are given off by the mycobacterium that cause TB. The readout for the end-user is an electronic signal that gives a rapid, positive/negative answer based on change in current. The sensor is simple to operate, requires no specialized biological reagents for sensing (i.e. antibodies, fluorescent tags, etc.), and requires a simple potentiostat for operation. This project has the potential to be developed into an inexpensive rapid POC device for screening populations at risk for TB using a breathalyzer like device that requires minimal training to operate.The broader impact/commercial potential of this project is substantial. TB is a devastating infectious disease in the world with approximately 14 million people worldwide infected. Although incidences within the Western World have declined, there is still a worldwide pandemic within countries of Asia and Africa. The company intends to address the market need for a rapid diagnosis of TB, specifically in endemic countries where there are insufficient resources for diagnosis of the disease in rural areas. In addition it is envisioned that this project will expand the application of the TiO2 nanotube sensing platform to other diseases beyond TB and other fields. For example VOBs are known to be associated with heart transplant rejection, lung cancer, ischemic heart disease, preeclampsia of pregnancy, diabetes mellitus, and breast cancer. The technology can also be applied to non-biomedical applications such as detection of volatile organic compounds in drinking water, and detection of improvised explosive devices.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Engineered Metal Functionalized TiO2 Nanotube Sensing Platform for Assessment of Pneumonia Volatile Biomarkers
  • 批准号:
    1706283
  • 项目类别:
    Standard Grant
  • 资助金额:
    $41.91万
  • 财政年份:
    2017
  • 负责人:
    Swomitra Mohanty
  • 依托单位:
国内基金
海外基金
Baryogenesis, Dark Matter and Nanohertz Gravitational Waves from a Dark Supercooled Phase Transition
  • 批准号:
    24ZR1429700
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    YUICHIRO NAKAI
  • 依托单位:
ATLAS实验探测器Phase 2升级
  • 批准号:
    11961141014
  • 项目类别:
    国际(地区)合作与交流项目
  • 资助金额:
    3350万元
  • 批准年份:
    2019
  • 负责人:
    刘衍文
  • 依托单位:
地幔含水相Phase E的温度压力稳定区域与晶体结构研究
  • 批准号:
    41802035
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    12.0万元
  • 批准年份:
    2018
  • 负责人:
    张里
  • 依托单位:
基于数字增强干涉的Phase-OTDR高灵敏度定量测量技术研究